Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives

키워드

참고문헌 (89)

1. Kwang Yong Shim, "Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension", The Korean Journal of Internal Medicine, 33(3), pp.453~461 (2018), 대한내과학회[DOI]
2. 김가은, "Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis", Clinical and Molecular Hepatology, 23(1), pp.34~41 (2017), 대한간학회[DOI]
3. Kang SH, "Novelties in the pathophysiology and management of portal hypertension : new treatments on the horizon", Hepatol Int, 12, pp.112~121 (2018)
4. Si-Tayeb K, "Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells", Hepatology, 51, pp.297~305 (2010)
5. Shu SN, "Hepatic differentiation capability of rat bone marrow-derived mesenchymal stem cells and hematopoietic stem cells", World J Gastroenterol, 10, pp.2818~2822 (2004)
6. 김가은, "Therapeutic Effects of Mesenchymal Stem Cells for Patients with Chronic Liver Diseases: Systematic Review and Meta-analysis", Journal of Korean Medical Science, 30(10), pp.1405~1415 (2015), 대한의학회
7. Secunda R, "Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix : a comparative study", Cytotechnology, 67, pp.793~807 (2015)
8. Ji ST, "Promising therapeutic strategies for mesenchymal stem cell-based cardiovascular regeneration : from cell priming to tissue engineering", Stem Cells Int, 2017, pp.3945403~ (2017)
9. Heo JS, "Neural transdifferentiation of human bone marrow mesenchymal stem cells on hydrophobic polymer-modified surface and therapeutic effects in an animal model of ischemic stroke", Neuroscience, 238, pp.305~318 (2013)
10. Dominici M, "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement", Cytotherapy, 8, pp.315~317 (2006)
11. Zarrabi M, "Potential uses for cord blood mesenchymal stem cells", Cell J, 15, pp.274~281 (2014)
12. Ribeiro A, "Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells", Stem Cell Res Ther, 4, pp.125~ (2013)
13. Kern S, "Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue", Stem Cells, 24, pp.1294~1301 (2006)
14. Liu WH, "The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases", J Cell Mol Med, 19, pp.511~520 (2015)
15. Banas A, "Stem cell plasticity : learning from hepatogenic differentiation strategies", Dev Dyn, 236, pp.3228~3241 (2007)
16. 엄영우, "Mesenchymal stem cell therapy for liver fibrosis", The Korean Journal of Internal Medicine, 30(5), pp.580~589 (2015), 대한내과학회[DOI]
17. Schwartz RE, "Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells", J Clin Invest, 109, pp.1291~1302 (2002)
18. Lange C, "Liver-specific gene expression in mesenchymal stem cells is induced by liver cells", World J Gastroenterol, 11, pp.4497~4504 (2005)
19. Ong SY, "Inducing hepatic differentiation of human mesenchymal stem cells in pellet culture", Biomaterials, 27, pp.4087~4097 (2006)
20. Dai LJ, "The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis", Stem Cell Res, 2, pp.16~25 (2009)
21. Kisseleva T, "The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis", J Hepatol, 56, pp.965~972 (2012)
22. Dmitrewski J, "Recurrence of primary biliary cirrhosis in the liver allograft : the effect of immunosuppression", J Hepatol, 24, pp.253~257 (1996)
23. Manousou P, "Primary biliary cirrhosis after liver transplantation : influence of immunosuppression and human leukocyte antigen locus disparity", Liver Transpl, 16, pp.64~73 (2010)
24. Sharma RR, "Mesenchymal stem or stromal cells : a review of clinical applications and manufacturing practices", Transfusion, 54, pp.1418~1437 (2014)
25. Ren G, "Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide", Cell Stem Cell, 2, pp.141~150 (2008)
26. Glennie S, "Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells", Blood, 105, pp.2821~2827 (2005)
27. Sotiropoulou PA, "Interactions between human mesenchymal stem cells and natural killer cells", Stem Cells, 24, pp.74~85 (2006)
28. Klyushnenkova E, "T cell responses to allogeneic human mesenchymal stem cells : immunogenicity, tolerance, and suppression", J Biomed Sci, 12, pp.47~57 (2005)
29. Lee KC, "Allo-transplantation of mesenchymal stem cells attenuates hepatic injury through IL1Ra dependent macrophage switch in a mouse model of liver disease", J Hepatol, 63, pp.1405~1412 (2015)
30. Parekkadan B, "Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells", Biochem Biophys Res Commun, 363, pp.247~252 (2007)
31. Wang J, "Inhibition of hepatic stellate cells proliferation by mesenchymal stem cells and the possible mechanisms", Hepatol Res, 39, pp.1219~1228 (2009)
32. Rabani V, "Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression", Cell Biol Int, 34, pp.601~605 (2010)
33. Chen S, "Activation of Notch1signaling by marrow-derived mesenchymal stem cells through cell-cell contact inhibits proliferation of hepatic stellate cells", Life Sci, 89, pp.975~981 (2011)
34. Semedo P, "Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model", Stem Cells, 27, pp.3063~3073 (2009)
35. Mohamadnejad M, "Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis", Arch Iran Med, 10, pp.459~466 (2007)
36. Kharaziha P, "Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection : a phase I-II clinical trial", Eur J Gastroenterol Hepatol, 21, pp.1199~1205 (2009)
37. Amer ME, "Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells", Eur J Gastroenterol Hepatol, 23, pp.936~941 (2011)
38. Peng L, "Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B : short-term and long-term outcomes", Hepatology, 54, pp.820~828 (2011)
39. El-Ansary M, "Phase II trial : undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis", Stem Cell Rev, 8, pp.972~981 (2012)
40. Shi M, "Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients", Stem Cells Transl Med, 1, pp.725~731 (2012)
41. Zhang Z, "Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients", J Gastroenterol Hepatol, 27(Suppl 2), pp.112~120 (2012)
42. Amin MA, "Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis : Egyptian study", Clin Transplant, 27, pp.607~612 (2013)
43. Mohamadnejad M, "Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis", Liver Int, 33, pp.1490~1496 (2013)
44. Wang L, "Pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis", J Gastroenterol Hepatol, 28(Suppl 1), pp.85~92 (2013)
45. Jang YO, "Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis : a pilot study", Liver Int, 34, pp.33~41 (2014)
46. Salama H, "Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease", Stem Cell Res Ther, 5, pp.70~ (2014)
47. Wang L, "Allogeneic bone marrow mesenchymal stem cell transplantation in patients with UDCA-resistant primary biliary cirrhosis", Stem Cells Dev, 23, pp.2482~2489 (2014)
48. Xu L, "Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis : regulation of Treg", Th17 cells, 2014, pp.29, 1620~1628
49. Suk KT, "Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis : Phase 2 trial", Hepatology, 64, pp.2185~2197 (2016)
50. Lanthier N, "Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?", Stem Cell Res Ther, 8, pp.88~ (2017)
51. Lin BL, "Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-onchronic liver failure : a randomized controlled trial", Hepatology, 66, pp.209~219 (2017)
52. Detry O, "Infusion of mesenchymal stromal cells after deceased liver transplantation : a phase I-II, open-label, clinical study", J Hepatol, 67, pp.47~55 (2017)
53. Meier RP, "Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence?", Stem Cell Res, 11, pp.1348~1364 (2013)
54. di Bonzo LV, "Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine : engraftment and hepatocyte differentiation versus profibrogenic potential", Gut, 57, pp.223~231 (2008)
55. Salama H, "Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases", Cell Transplant, 19, pp.1475~1486 (2010)
56. Mishra PJ, "Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells", Cancer Res, 68, pp.4331~4339 (2008)
57. Zhou YF, "Spontaneous transformation of cultured mouse bone marrow-derived stromal cells", Cancer Res, 66, pp.10849~10854 (2006)
58. Miura M, "Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation", Stem Cells, 24, pp.1095~1103 (2006)
59. Dahl JA, "Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum", Int J Dev Biol, 52, pp.1033~1042 (2008)
60. Dhawan A, "Human hepatocyte transplantation : current experience and future challenges", Nat Rev Gastroenterol Hepatol, 7, pp.288~298 (2010)
61. Alwahsh SM, "Liver cell therapy: is this the end of the beginning?", Cell Mol Life Sci, 75, pp.1307~1324 (2018)
62. Zeilinger K, "Cell sources for in vitro human liver cell culture models", Exp Biol Med(Maywood), 241, pp.1684~1698 (2016)
63. Godoy P, "Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME", Arch Toxicol, 87, pp.1315~1530 (2013)
64. Li J, "3D PLGA scaffolds improve differentiation and function of bone marrow mesenchymal stem cell-derived hepatocytes", Stem Cells Dev, 19, pp.1427~1436 (2010)
65. Liu M, "Superior performance of co-cultured mesenchymal stem cells and hepatocytes in poly(lactic acid-glycolic acid)scaffolds for the treatment of acute liver failure", Biomed Mater, 11, pp.015008~ (2016)
66. Mazza G, "Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation", Sci Rep, 5, pp.13079~ (2015)
67. Deschepper M, "Survival and function of mesenchymal stem cells(MSCs)depend on glucose to overcome exposure to long-term, severe and continuous hypoxia", J Cell Mol Med, 15, pp.1505~1514 (2011)
68. Yu SP, "Preconditioning strategy in stem cell transplantation therapy", Transl Stroke Res, 4, pp.76~88 (2013)
69. Haider H, "Preconditioning and stem cell survival", J Cardiovasc Transl Res, 3, pp.89~102 (2010)
70. Feng Y, "Heat shock improves Sca-1+stem cell survival and directs ischemic cardiomyocytes toward a prosurvival phenotype via exosomal transfer : a critical role for HSF1", miR-34a, Stem Cells, pp.2014, 32[DOI]
71. Qiao PF, "Heat shock pretreatment improves stem cell repair following ischemia-reperfusion injury via autophagy", World J Gastroenterol, 21, pp.12822~12834 (2015)
72. Sandvig I, "Strategies to enhance implantation and survival of stem cells after their injection in ischemic neural tissue", Stem Cells Dev, 26, pp.554~565 (2017)
73. Beegle J, "Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivo", Stem Cells, 33, pp.1818~1828 (2015)
74. Das R, "The role of hypoxia in bone marrow-derived mesenchymal stem cells : considerations for regenerative medicine approaches", Tissue Eng Part B Rev, 16, pp.159~168 (2010)
75. Carrière A, "Preconditioning by mitochondrial reactive oxygen species improves the proangiogenic potential of adipose-derived cells-based therapy", Arterioscler Thromb Vasc Biol, 29, pp.1093~1099 (2009)
76. Alfaifi M, "Mesenchymal stromal cell therapy for liver diseases", J Hepatol, 68, pp.1272~1285 (2018)
77. Di Rocco G, "Enhanced healing of diabetic wounds by topical administration of adipose tissue-derived stromal cells overexpressing stromal-derived factor-1 : biodistribution and engraftment analysis by bioluminescent imaging", Stem Cells Int, 2011, pp.304562~ (2010)
78. Mangi AA, "Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts", Nat Med, 9, pp.1195~1201 (2003)
79. Kutschka I, "Adenoviral human BCL-2transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts", Circulation, 114, pp.I174~I180 (2006)
80. Liu N, "Effects of transplantation with bone marrow-derived mesenchymal stem cells modified by Survivin on experimental stroke in rats", J Transl Med, 9, pp.105~ (2011)
81. Chen S, "Hepatocyte growth factor-modified mesenchymal stem cells improve ischemia", reperfusion-induced acute lung injury in rats, 2017, pp.24, 3~11
82. Hu S, "Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation", Circulation, 124, pp.S27~S34 (2011)
83. Xu J, "miR-210 over-expression enhances mesenchymal stem cell survival in an oxidative stress environment through antioxidation and c-Met pathway activation", Sci China Life Sci, 57, pp.989~997 (2014)
84. Camussi G, "Role of stem-cell-derived microvesicles in the paracrine action of stem cells", Biochem Soc Trans, 41, pp.283~287 (2013)
85. Koppers-Lalic D, "Virus-modified exosomes for targeted RNA delivery; a new approach in nanomedicine", Adv Drug Deliv Rev, 65, pp.348~356 (2013)
86. Kooijmans SAA, "Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles : new nanotools for cancer treatment", Pharmacol Res, 111, pp.487~500 (2016)
87. Li T, "Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis", Stem Cells Dev, 22, pp.845~854 (2013)
88. Nong K, "Hepatoprotective effect of exosomes from human-induced pluripotent stem cell-derived mesenchymal stromal cells against hepatic ischemia-reperfusion injury in rats", Cytotherapy, 18, pp.1548~1559 (2016)
89. Du Y, "Exosomes from human-induced pluripotent stem cell-derived mesenchymal stromal cells(hiPSC-MSCs)protect liver against hepatic ischemia", reperfusion injury via activating sphingosine kinase and sphingosine-1-phosphate signaling pathway, 2017, pp.43, 611~625